XTalks

OCTOBER 24, 2024

Panagos, an industry veteran with extensive experience in the healthcare and life sciences sector, takes over from Colin Shannon, who served as CEO for one year following the company’s acquisition by a consortium of private equity firms. Shannon has now been appointed Executive Chairman of Syneos.

Life Science 105

Life Science Clinical Development Development Clinical Research 105

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been? But these are not sustainable.

Life Science 98

Life Science Engineer Scientist Doctor 98

Pharmaceutical Technology

JUNE 9, 2023

Co-led by Venrock Healthcare Capital Partners (Venrock) and Enavate Sciences, the financing round has seen participation from new investors Wellington Management and Bain Capital Life Sciences.

Clinical Development 147

Clinical Development Development Life Science Clinical Trials 147

XTalks

FEBRUARY 5, 2025

In this episode, Ayesha spoke with Mario Marcondes, MD, PhD, VP Head of Clinical Development at Nektar Therapeutics , a company focused on the discovery and development of novel therapies for autoimmune disorders and cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Clinical Development 59

Clinical Development Development Life Science Clinical Trials 59

Outsourcing Pharma

APRIL 16, 2024

Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.

Life Science 81

Life Science Clinical Development Development 81

Pharmaceutical Technology

JUNE 6, 2023

Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. Gildeuretinol is the first and only medicine in clinical development to treat Stargardt disease by reducing vitamin A dimerization in the eye, without affecting normal vision.

Genetics 279

Genetics Life Science Trials Clinical Development 279

XTalks

APRIL 14, 2021

FDA-mandated clinical holds, strategic partnership breakups and $800 million biotech acquisitions. She shares how well the firms have weathered the COVID-19 pandemic, and the team discusses the outlook for the drug development industry in general. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 75

Life Science Gene Therapy Development Drugs 75

Outsourcing Pharma

AUGUST 22, 2023

Those in the life sciences industry needing some creative input can now turn to Bios Health Group who have recently launched into the space.

Life Science 81

Life Science Clinical Development Development 81

XTalks

JUNE 4, 2024

Oren Cohen, MD, FIDSA CMO & President of Clinical Pharmacology Fortrea Fortrea is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, market access solutions and other enabling services.

Clinical Development 110

Clinical Development Development Clinical Trials Clinical Trials 110

Pharmaceutical Technology

AUGUST 9, 2022

In the clinical development programme, 1,944 epilepsy patients received cenobamate treatment. Discovered by SK Biopharmaceuticals and SK life science, cenobamate is a new small molecule anti-seizure therapy.

Life Science 246

Life Science Clinical Development Trials Marketing 246

XTalks

JANUARY 5, 2021

The burden of clinical trials is on all patient groups and patient segments. Therefore, we should always have a patient-centric focus with study design for clinical development.” And that will require engaging more with a patient to make sure that their voice is being heard during protocol development.”. [All

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

MAY 28, 2024

The traditional clinical trials model is facing scrutiny. Marked by high costs ranging from $1 billion to $2 billion, lengthy timelines extending five to ten years and success rates falling below ten percent, there is a pressing need for reform.

Clinical Development 116

Clinical Development Development Clinical Trials Clinical Trials 116

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. This helps to reduce human error and provide more reliable, replicable results and increase the speed of drug discovery and development processes.

Development 311

Development Drugs Pharma Companies Life Science 311

ACRP blog

OCTOBER 10, 2024

The same is true in life sciences. Challenges and Opportunities in Life Sciences As an industry, we lack the fundamental building blocks to support AI development. AI’s margin gains simply aren’t as big an incentive for life sciences businesses to embark on multi-year data engineering projects.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Life Science 69

BioTech 365

SEPTEMBER 29, 2021

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership CAMBRIDGE & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc (AIM: AVCT), a clinical stage … Continue reading → (..)

Life Science 40

Life Science Clinical Development Development 40

XTalks

JANUARY 7, 2025

billion Announced : February 2019 Closed : March 2020 In 2019, Danaher, a life sciences and diagnostics innovator, acquired the Biopharma business from General Electric Companys (GE) Life Sciences division. Now operating as Cytiva, the business functions as a standalone company within Danahers Life Sciences segment.

Life Science 105

Life Science Manufacturing Production Clinical Development 105

pharmaphorum

JANUARY 5, 2024

Beckley Psytech has announced that is has received substantial strategic investment from atai Life Sciences, totalling $50 million, to accelerate the clinical development of short-duration psychedelics.

Life Science 97

Life Science Clinical Development Development 97

XTalks

OCTOBER 23, 2024

Tune in to learn how CTTI is leading efforts to reshape clinical trials. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Clinical Research 64

Clinical Research Clinical Trials Clinical Trials Life Science 64

Pharmaceutical Technology

MAY 24, 2023

The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

XTalks

NOVEMBER 13, 2024

As Chief Medical and Scientific Officer at Click Therapeutics and a Board Director at SpineThera, he spearheads AI-enabled clinical development and drug-delivery platforms. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 59

Life Science Medicine Drug Delivery Clinical Development 59

Cloudbyz

SEPTEMBER 11, 2024

This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to life sciences organizations worldwide. This prestigious recognition positions Cloudbyz among the top performers in delivering intuitive and scalable EDC solutions to life sciences organizations worldwide.

Life Science 52

Life Science Clinical Trials Clinical Trials Compliance 52

XTalks

NOVEMBER 26, 2024

Patient advocacy groups, including the Amyloidosis Support Groups led by Muriel Finkel, highlight the transformative impact of Attruby on the lives of those with ATTR-CM.

Genetic Disease 105

Genetic Disease Genetics Protein Clinical Development 105

XTalks

DECEMBER 10, 2024

The LUNA 3 study enrolled 202 adults with persistent or chronic ITP and severely low platelet counts, averaging just 15,000 per microliter well below the normal range of 150,000 to 450,000 per microliter.

Trials 104

Trials Protein Clinical Development Drugs 104

BioTech 365

MAY 12, 2021

Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates Kezar Life Sciences Reports First Quarter Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in … Continue reading →

Life Science 40

Life Science Clinical Development Development 40

XTalks

NOVEMBER 15, 2023

This episode features an interview with Dr. Lahar Mehta, Head of Global Clinical Development at Amylyx Pharmaceuticals, who spoke to Xtalks about Amylyx’s clinical trial design of ORION, a Phase III Global Study of AMX0035 (Relyvrio) in Progressive Supranuclear Palsy (PSP).

Life Science 52

Life Science Trials Clinical Trials Clinical Trials 52

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.

Vaccine 141

Vaccine Vaccination Manufacturing Clinical Development 141

Pharmaceutical Technology

APRIL 12, 2023

Cognizant Life Sciences global head Srini Shankar said: “Utilising advanced technologies to improve the quality and delivery of novel medicines is a must for innovative pharmaceutical companies, and Boehringer Ingelheim stands out for their forward thinking in pursuing development of the One Medicine Platform.

Medicine 130

Medicine Life Science Development Branding 130

Outsourcing Pharma

JULY 27, 2021

A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.

Life Science 111

Life Science Clinical Development Development 111

BioTech 365

MARCH 11, 2021

Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates KZR-616 clinical development in three severe autoimmune diseases … Continue reading →

Life Science 40

Life Science Clinical Development Development 40

Outsourcing Pharma

MARCH 9, 2021

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

Life Science 73

Life Science Development Clinical Development 73

pharmaphorum

SEPTEMBER 3, 2020

In a filing with the US financial regulator Compass laid out its plans to develop the drug known as COMP360, which is a crystalline formulation of psilocybin in phase 2b clinical development in patients who have not responded to standard therapy for depression.

Drugs 116

Drugs Life Science Clinical Development Regulation 116

The Pharma Data

MARCH 15, 2022

Global Head of Blackstone Life Sciences “We are excited to collaborate with Sanofi’s experienced development team to advance a subcutaneous dosage form for Sarclisa for patients. About Blackstone Life Sciences. Nicholas Galakatos, Ph.D.

Life Science 52

Life Science Antibody Medicine Clinical Trials 52

XTalks

NOVEMBER 21, 2024

Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide)/GLP-1 (glucagon-like peptide-1) receptor agonist, has been a blockbuster treatment for type 2 diabetes and obesity, along with semaglutide rivals Ozempic and Wegovy from Novo Nordisk.

Sales 105

Sales Insulin Drugs Trials 105

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccine Vaccination Scientist 52

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 114

Life Science Scientist Engineer Pharma Companies 114

Outsourcing Pharma

APRIL 15, 2024

Michael Fronstin, global head of client partnership and commercialization at the company said the combination of Oracleâs life sciences expertise and platform technology help CROs win more business and run trials more efficiently.

Life Science 95

Life Science Trials Clinical Development Development 95

The Pharma Data

JANUARY 14, 2021

” About Awakn Life Sciences. Awakn Life Sciences is a biotechnology company focused on the research, development, and delivery of psychedelic medicines for the treatment of mental health conditions. The data from this trial will be used to progress into our phase III study.”

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52